Phase 4 Clinical Trial
Support Platforms
Leading pharmaceutical companies — including industry giants like Bayer, MSD, Merck, and BMS — partnered with We As Web to build custom, centralized electronic platforms for managing Phase 4 clinical trials. The platforms feature dynamic criteria management, automated eligibility reporting, and state-of-the-art encryption for strict GDPR and HIPAA compliance.
Discuss Your Project →Phase 4 clinical trials held back by manual tracking and rigid eligibility systems
Leading pharmaceutical companies — including industry giants like Bayer, MSD, Merck, and BMS — require robust infrastructures to manage Phase 4 clinical trials effectively. These post-marketing studies demand rigorous monitoring of patient progress, treatment efficacy, and safety data. The clients partnered with We As Web to build custom, centralized electronic platforms that could replace manual tracking efforts, disseminate trial results, and safely handle sensitive medical data across diverse studies.
What prompted the project
To successfully manage Phase 4 clinical trials, the pharmaceutical clients needed a centralized, secure, and flexible platform — capable of supporting the realities of post-marketing studies.
Manage Patient Databases
A highly secure environment to store and manage sensitive patient information throughout the trial lifecycle.
Automate Eligibility
Automatically generate eligibility reports for patients based on specific study requirements — no manual data processing.
Centralize Trial Tracking
A unified hub for tracking patient progress and treatments continuously throughout the study.
Disseminate Results
A reliable channel for sharing ongoing trial results and insights with the right stakeholders.
Why an expert partner was required
The development of these clinical trial platforms faced two primary, high-stakes hurdles — one operational, one regulatory.
What We As Web delivered
We As Web designed and implemented highly tailored platforms (6 months to 2 years per platform depending on complexity) featuring four core solutions.
Dynamic Criteria Management
A flexible system that allows trial sponsors to update and refine patient eligibility requirements in real-time.
Automated Reporting Engine
Automation that generates patient eligibility reports — no manual data processing.
Centralized Trial Hub
A unified interface for disseminating trial results and monitoring patient treatments and progress.
Advanced Security & Privacy
State-of-the-art encryption methods and secure data storage for strict GDPR, HIPAA, and other regulatory compliance.
Lower admin overhead, faster decisions, better trials
The deployment of these custom clinical trial platforms delivered significant operational efficiencies for the clients.
The automated data processing and eligibility reporting successfully reduced the administrative workload for pharmaceutical companies by 40%.
The manual effort previously required to track patient eligibility and monitor ongoing progress was drastically reduced.
Real-time insights into patient progress and treatment allowed clinical teams to make quicker, more effective decisions, raising the overall efficiency of the trials.
Clients praised the platform's user-friendly design and its flexibility in adapting to the unique requirements of different clinical studies.
Custom platforms for Phase 4 trial operations
A purpose-built stack — dynamic criteria engines, advanced encryption, and compliant data storage — designed for the rigor of post-marketing trials.
When clinical trial operations can't be held back by manual tracking
Phase 4 clinical trials are where approved drugs meet the real world — and they need platforms designed for the rigor of post-marketing studies. By building custom, dynamic-criteria systems with automated eligibility reporting, centralized trial tracking, and advanced encryption for GDPR and HIPAA compliance, we enabled leading pharmaceutical companies to manage their trials with less admin overhead and faster decisions.
The result is a 40% reduction in administrative workload, drastically streamlined patient management, and the flexibility to adapt to the unique requirements of different studies. For any pharmaceutical company running Phase 4 trials, this is what a purpose-built, compliance-first platform looks like in production.